Zero tolerance

Transfusion

Volumn 47, Issue 7, 2007, Pages 1106-1109

  Prowse, C ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN;

BACTERIAL GROWTH; BACTERIAL INFECTION; BLOOD BANK; BLOOD TRANSFUSION; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; SCREENING; SHELF LIFE; THROMBOCYTE; VASCULARIZATION; VIRUS INFECTION;

BACTERIA; BACTERIAL INFECTIONS; BLOOD; BLOOD PRESERVATION; HUMANS;

EID: 34250650032     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01322.x     Document Type: Editorial

References (29)

1. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med 1969 280 : 1094 8.
2. Reduction of the maximum platelet storage period to 5 days in an approved container [monograph on the Internet]. Memo from Director, Office of Biologics Research and Review. Rockville (MD) : U.S. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration 1986 Jun 2. Available from: http://www.fda.gov/cber/bldmem/060286.pdf
3. Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Muylle L. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005 19 : 259 72.
4. Silva M, editor. Standards for blood banks and transfusion services. 24th ed. Bethesda : American Association of Blood Banks 2006.
5. PASSPORTstudy.com [homepage on the Internet]. Lakewood (CO) and Deerfield (IL) : Gambro BCT and Baxter c2007. Available from: http://www.passportstudy. com/default.asp.
6. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005 45 : 1845 52.
7. Holme S, Bunch C, Selman B. Bacterial contamination in stored platelets: performance of the Pall eBDS system under routine use conditions (P-194). Vox Sang 2005 89 (Suppl 1 95.
8. Ramírez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M. Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007 47 : 421 9.
9. Janssen MP, van der Poel CL, Buskens E, Bonneux L, Bonsel GJ, van Hout BA. Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands. Transfusion 2006 46 : 956 65.
10. Kleinman SH, Kamel HT, Harpool DR, et al. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006 46 : 1787 94.
11. Schrezenmeier H, Walther-Wenke G, Müller TH, et al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007 47 : 644 52.
12. McDonald CP. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus Med 2006 16 : 381 96.
13. Delage G, Itaj NK, Robillard P. Cumulative effect of preventative measures on incidence of bacterial infections in platelet recipients (S-89-040F). Transfusion 2006 46 (Suppl 33A.
14. Benjamin RJ, Mintz PD. Bacterial detection and extended platelet storage: the next step forward. Transfusion 2005 45 : 1832 5.
15. AuBuchon JP. The reliability of bacterial detection in platelets. ISBT Sci Series 2006 1 : 59 63.
16. Kaufman RM. Platelets: testing, dosing and the storage lesion - recent advances. Hematology, Am Soc Hematol Educ Program 2006 : 492 6.
17. Lee CK, Ho PL, Lee KY, et al. Estimation of bacterial risk in extending the shelf life of PLT concentrates from 5 to 7 days. Transfusion 2003 43 : 1047 52.
18. Dickmeiss E, Bidstrup M, Salado J. The importance of the sampling time after the preparation of platelet concentrates for the detection of bacterial contamination (2PS-05-04). Vox Sang 2006 91 (s3 10.
19. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006 20 : 273 82.
20. Aubuchon JP. A sensitivity model for post-storage bacterial detection systems (SP41). Transfusion 2006 46 (9S 51A.
21. Verax Biomedical Submits 510(k) Application To FDA For Platelet PGD Test [monograph on the Internet]. East Sussex : Medical News Today 2007 Mar 15. Available from http://www.medicalnewstoday.com/medicalnews.php?newsid=65253.
22. Nussbaumer W, Allersdorfer D, Grabmer C, et al. Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. Transfusion 2007 47 : 1125 33.
23. van Rhenen D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003 101 : 2426 33.
24. Snyder E, McCullough J, Slichter SJ, et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005 45 : 1864 75.
25. Lin L, Dikeman R, Molini B, et al. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004 44 : 1496 504.
26. Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006 35 : 5 17.
27. Mohr H, Redecker-Klein A. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang 2003 84 : 96 104.
28. Brecher ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R. Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion 2000 40 : 1308 12.
29. Angelini M, Fressy P, Rasongles P. Epidémie de Chikungunya à la Réunion et transfusion sanguine. [en ligne: http://agmed.sante.gouv.fr/htm/5/indbhemo.htm ]. Hémovigilance 2006 13 : 9 10.